Please read Dr. Neibart’s article in the Journal of Thoracic Disease titled, “Pneumonitis in Advanced Non-Small Cell Lung Cancer: No Interaction between Immune Checkpoint Inhibition and Radiation Therapy.“
Pneumonitis is a common complication of treatment for advanced non-small cell lung cancer (NSCLC). Radiation pneumonitis and immune-related pneumonitis have been studied independently, but little information has emerged on the interactions between radiation therapy (RT) and immune checkpoint inhibition (ICI). In this study, we aim to examine if RT and ICI interact in causing pneumonitis. To read the full article.
Pneumonitis in Advanced Non-Small Cell Lung Cancer: No Interaction between Immune Checkpoint Inhibition and Radiation Therapy. Neibart S, Malhotra J, Roy JA, Strom BL, Jabbour. International Journal of Radiation Oncology-Biology-Physics. Volume 114, Issue 3, Supplement, 1 November 2022, Pages e384-e385. DOI: 10.1016/j.ijrobp.2022.07.1534